Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): Overall survival results of a phase 3 randomised trial

Amit M. Oza, Adrian D. Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A. Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Tjoung-Won Park-Simon, Gordon Rustin, Florence Joly, Mansoor R. Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C. Jayson, Dan Stark, Ann Marie SwartLaura Farrelly, Richard Kaplan, Mahesh K. B. Parmar, Timothy J. Perren, ICON7 trial investigatorsShow 5 moreShow less